LTI0
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloi… Read more
LTI0 (LTI0) - Total Assets
Latest total assets as of September 2025: €6.34 Million EUR
Based on the latest financial reports, LTI0 (LTI0) holds total assets worth €6.34 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
LTI0 - Total Assets Trend (2021–2024)
This chart illustrates how LTI0’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
LTI0 - Asset Composition Analysis
Current Asset Composition (December 2024)
LTI0's total assets of €6.34 Million consist of 94.1% current assets and 5.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 60.8% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how LTI0's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LTI0's current assets represent 94.1% of total assets in 2024, a decrease from 99.1% in 2021.
- Cash Position: Cash and equivalents constituted 60.8% of total assets in 2024, up from 47.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
LTI0 Competitors by Total Assets
Key competitors of LTI0 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
LTI0 - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - LTI0 generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - LTI0 is currently not profitable relative to its asset base.
LTI0 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.53 | 1.05 | 1.05 |
| Quick Ratio | 0.53 | 1.05 | 1.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-3.30 Million | € 477.00K | € 477.00K |
LTI0 - Advanced Valuation Insights
This section examines the relationship between LTI0's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | -22.0% |
| Total Assets | €10.13 Million |
| Market Capitalization | $2.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values LTI0's assets below their book value (0.29 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: LTI0's assets decreased by 22.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for LTI0 (2021–2024)
The table below shows the annual total assets of LTI0 from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €10.13 Million | -22.03% |
| 2023-12-31 | €12.99 Million | -74.54% |
| 2022-12-31 | €51.03 Million | -38.17% |
| 2021-12-31 | €82.53 Million | -- |